Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM): Protocol for a randomized, pragmatic trial.

Carmen Garrigós VacasClara María Rosso-FernándezIrene BorregueroPatricia RodríguezRaquel García-AlbeaJose María Bravo-FerrerJesús Rodríguez-BañoMaria Dolores Del Toronull null

Published in: PloS one (2023)

This trial is registered at ClinicalTrials.gov (NCT05294796) on Jan 26th 2022 and at the European Union Drug Regulating Authorities Clinical Trials (EUDRACT) (2021-003914-38) on Jul 16th 2021. The Sponsor Study Code is DURATIOM.

Keyphrases

clinical trial
study protocol
phase iii
phase ii
randomized controlled trial
open label
staphylococcus aureus
bone mineral density
double blind
bone regeneration
combination therapy
postmenopausal women
emergency department
adverse drug
drug induced
placebo controlled
bone loss
body composition